Sofiva Genomics Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sofiva Genomics Co Ltd with three other
companies in this sector in Taiwan:
Medigen Biotechnology Corporation
sales of 407.31 million Taiwanese Dollars [US$13.35 million]
of which 83%
was Drug Discovery),
Genomics Biosci &Tech Co Ltd
(438.69 million Taiwanese Dollars [US$14.38 million]
Welgene Biotech Co Ltd
(384.43 million Taiwanese Dollars [US$12.60 million]
Sofiva Genomics Co Ltd reported sales of 459.40 million Taiwanese Dollars (US$15.06 million)
December of 2018.
increase of 8.4%
versus 2017, when the company's sales were 423.94 million Taiwanese Dollars.
Sales at Sofiva Genomics Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 198%).